XGN logo

XGNExagen Inc

$4.79
$0.25
(5.51%)
Today
Closed $4.79
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 11
Mkt Cap$109.69M
Vol245,463.00
44

Bearish Sentiment

How do you feel about XGN?

News
all
press releases
How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%
The average of price targets set by Wall Street analysts indicates a potential upside of 73.1% in Exagen (XGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
More News
News Placeholder
Exagen (XGN) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
Exagen Q1 Earnings Call Highlights
Exagen Q1 Earnings Call Highlights...
Yahoo! Finance: News
News Placeholder
The New Spec Supercycle
Momentum traders are once again crowding into emerging growth sectors as artificial intelligence infrastructure, defense modernization, advanced medical technologies, and digital asset finance combine to create one of the market’s most aggressive speculative environments in years. Several names touched new 52-week highs Monday morning alongside major technology leaders including NVIDIA (NASDAQ:NVDA). $ODYS, $KBLB, $DGXX, $BW, $XGN, $MEHA, $NVDA
24-7 Market News
News Placeholder
Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of +29.17% and +4.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
AtriCure (ATRC) Reports Break-Even Earnings for Q1
AtriCure (ATRC) delivered earnings and revenue surprises of +100.00% and +1.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates
Zimmer (ZBH) delivered earnings and revenue surprises of +12.57% and +1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Exagen Inc. (NASDAQ:XGN) Sees Large Decrease in Short Interest
Exagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totaling 729,740 shares, a decline of 52.5% from...
MarketBeat
News Placeholder
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts
Exagen Inc. (NASDAQ:XGN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating and nine have issued a buy rating on the company. The average 1...
MarketBeat
News Placeholder
Exagen (NASDAQ:XGN) Cut to "Sell" at Wall Street Zen
Wall Street Zen downgraded shares of Exagen from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.